Pregnancy loss was more common for couples when the father had medical comorbidities, reported Michael Eisenberg, MD, of Stanford University, in Human Reproduction. By Amanda D'Ambrosio. bit.ly/34p8usK

Today’s #SSMRJournalClub is by Michael Eisenberg and Alex Kasman, MD, from Human Reproduction - on the association between preconception paternal health and pregnancy loss. #urology #malefactor #maleinfertility Stanford Urology #UroSoMe #paternalage pubmed.ncbi.nlm.nih.gov/33336240/ (1/n)

#COVID19 lockdowns in the U.S. actually might have led to increased male sexual frequency without impacting overall function. #UroSoMe #Menshealth Michael Eisenberg Hriday Bhambhvani, MD Alex Kasman, MD ISSM doi.org/10.1016/j.esxm…

In a prospective, randomized trial involving patients with urothelial carcinoma who had undergone radical surgery, adjuvant nivolumab was compared with placebo. The median disease-free survival was 20.8 months with nivolumab and 10.8 months with placebo.

🇸🇪 randomised trial - presented at #EAU21 & published at NEJM: MRI with targeted biopsy vs standard noninferior to standard biopsy for detecting clinically significant prostate cancer but resulted in less detection of clinically insignificant cancers nejm.org/doi/pdf/10.105…

What Are Trends in Testosterone Therapy use Amongst Prostate Cancer Survivors in the United States? #ProstateCancer #Testosterone #Hypogonadism ow.ly/rz9J50FHqTe

In a 1,000-patient trial, pembrolizumab injections led to improved disease-free survival at 2 years. nej.md/3iQCncK

🚨New AUA Whitepaper🚨 Rationale and Strategies for Reducing Urologic Post-Operative Opioid Prescribing The goal of this whitepaper is to explore evidence & outline strategies for managing post-operative urologic pain w/ minimal to no opioid prescribing. bit.ly/3t04bim

Fruitful collaboration with BAUS on this timely and important topic- Expedited Radical Orchidectomy for Testicular Cancer: Compromising Fer... sciencedirect.com/science/articl… Maj Shabbir Cameron Alexander Veeru Kasi Anthony Emmanuel Nikita Bhatt Vinson Chan Abi Kanthabalan.

#covid19 #vaccine is SAFE for #malefertility. Really important work done by @ranjithramamd and colleagues. #getvaccinated #aua21

Exercise 🏃‍♂️ increased cardiorespiratory fitness levels and ↘️ PSA levels, PSA velocity, and prostate cancer cell growth in men with localized #prostatecancer who were under active surveillance! JAMA Oncology OncoAlert Prostate Cancer Foundation Advanced Prostate Cancer Consensus Conference European Association of Urology (EAU) UroToday.com jamanetwork.com/journals/jamao…

"Appropriateness Criteria for Ureteral Stent Omission following Ureteroscopy for Urinary Stone Disease" 🔗 bit.ly/3xcpm4z By: Spencer C. Hiller, Stephanie Daignault-Newton, Ivan Rakic, Susan Linsell, Bronson Conrado et al. #Urology

Current Issue: Initial Experience with Apixaban for Extended Venous Thromboembolism Prophylaxis After Radical Cystectomy buff.ly/3I0gtid Geoff Rosen Taha Anwar 陆菲 KATIE MURRAY #urolology #medtwitter

Is exam needed before #vasectomy? This study 📚 suggests not- no differences were seen in rates of completed vasectomies for men doing TM vs F2F consult, suggesting that a exam is not required to predict successful completion of the procedure. @SarahLacyC pubmed.ncbi.nlm.nih.gov/35788017/

Doctors at a major US insurance company deny tens of thousands of claims a month without even looking at patients’ files. “We literally click & submit,” a former Cigna doctor told @ProPublica & The Capitol Forum. “It takes all of 10 seconds to do 50 at a time.” The inside story 🧵

In men with hypogonadism and preexisting or a high risk of cardiovascular disease, testosterone-replacement therapy was noninferior to placebo with respect to the incidence of major adverse cardiac events. nej.md/3Ja6c4N #ENDO2023

Excited to do the first Valencia Technologies eCoin implants at PAMF/Sutter Health NorCal today for urge urinary incontinence! Exciting new option to offer patients with overactive bladder

Our collaborative review on LND in GU cancers; tremendous effort by Amanda Myers MD Anderson Cancer Center #OncSurgery European Urology Oncology Open Access link: authors.elsevier.com/a/1i6Q09Cfv-xp… Alberto Briganti B.C. Leibovich MD #SethLerner Marco Moschini Morgan Roupret Shahrokh F. Shariat Philippe spiess @Astenzl

Prostate safety is a concern of men considering testosterone treatment. In the TRAVERSE Trial, a large testosterone RCT in men with hypogonadism, rates of prostate cancer and other prostate events were low and did not differ vs placebo. ja.ma/3NISh88

Yesterday’s TRAVERSE paper has instantly changed clinical practice and scientific concepts. Hugely impactful. Kudos to Mohit Khera and the other investigators. My thoughts- A 🧵: 1/n